Pre-market Hot Trades in US Stocks
Credo Tech is down 4.63% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, Credo Tech's valuation was considered high, with a price-to-earnings ratio reaching 38 times, raising market concerns about its future profitability. Analysts pointed out that if Credo fails to achieve higher-than-expected revenue growth in the coming quarters, its stock price may face pressure. Source: 24/7 Wall St.
</li>
<li>
On May 14, Credo Tech's PEG ratio indicated that its pricing relative to growth rate is below the industry average, and the market holds an optimistic view of its future growth. Several top investment banks have given buy ratings, with target prices above the current stock price. Source: Chinese Investment Network
</li>
<li>
On May 12, Credo Tech was not included in MarketBeat's list of the top five recommended stocks, despite its rating being moderately buy, as analysts believe other stocks are more attractive. Source: MarketBeat The semiconductor sector has recently gained popularity, and risks need to be monitored.
</li>
</ol>
Galaxy Digital is down 4.24% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 12, Galaxy Digital partnered with Sharplink to establish an on-chain yield fund, planning to invest $125 million, with Galaxy contributing $25 million. This move aims to maintain Sharplink's core ETH exposure through DeFi liquidity protocols and on-chain yield strategies, driving volatility in Galaxy's stock price.
</li>
<li>
On May 15, Multicoin Capital reportedly sold 150,000 AAVE at a price of $99, expected to incur a loss of over $40.56 million. Some AAVE transferred to Galaxy Digital may impact its financial performance, leading to a decline in stock price.
</li>
<li>
On May 14, Galaxy Digital was rated with a momentum grade of A+, a valuation grade of A+, and a quantitative rating of 4.86, indicating high market expectations for its future performance, but the stock price still faces volatility in the short term. The cryptocurrency market is experiencing increased volatility, and risks need to be monitored.
</li>
</ol>
Top Gainers in Pre-market US Stocks
HCW Biologics is up 196.05% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, HCW Biologics announced that its drug HCW11-040 was found to prevent bronchopulmonary dysplasia (BPD) in IND-enabled research, significantly boosting its stock price. The company expects to complete the research and submit the IND application in the second half of 2027, enhancing market confidence in its R&amp;D capabilities.
</li>
<li>
On May 14, HCW Biologics released its Q1 2026 financial report, showing a basic earnings per share of $0.37, exceeding market expectations. The positive data in the financial report further stimulated the rise in stock price
On May 15, analysts gave HCW Biologics a &#34;Buy&#34; rating, with Wall Street's 12-month price target set at $2.00, approximately 472.4% higher than the closing price of $0.35 on May 13. This optimistic analyst expectation supports the stock price. The biotechnology sector has shown strong performance recently, with significant capital inflows.
</li>
</ol>
Dreamland pre-market rose 106.25%. Based on recent key news:
<ol>
<li>
On May 12, Dreamland signed a memorandum of understanding with LinkFung Innovation to develop an AI-driven smart image library platform. This collaboration aims to enhance services through technology, expand market influence, and drive stock price increases.
</li>
<li>
On May 13, Dreamland's stock price surged 126.92%, closing at $2.36, with a trading volume of approximately $219 million. This unusual movement was primarily driven by speculative capital inflow, with market sentiment running high and technical indicators showing extreme overbought conditions.
</li>
<li>
On May 14, technical analysis indicated that Dreamland's stock price significantly deviated from short-term moving averages, with an RSI of 97.75, suggesting heightened market optimism but also the risk of a pullback. The film entertainment industry has not seen any major positive developments recently.
</li>
</ol>
Auddia pre-market rose 66.33%. Based on recent key news:
<ol>
<li>
On May 15, Auddia submitted an S-4 filing to merge with Thramann Holdings, establishing McCarthy Finney as a unified AI platform. This move is seen as an important step in the company's strategic expansion, driving a significant increase in stock price. Source: Reuters
</li>
<li>
On May 12, Auddia's directors and executives participated in a proxy solicitation related to the merger transaction, with relevant information to be disclosed in the S-4 filing. This information has increased market confidence in the success of the merger, further stimulating stock price increases. Source: Auddia Inc.
</li>
<li>
On May 12, Auddia communicated with investors and the public through its official website, emphasizing the role and interests of its management in the merger transaction. This transparency has enhanced investor trust, supporting the rise in stock price. Source: Auddia Inc
</li>
</ol>

CRDO

GLXY

Credo Tech fell 4.63% in pre-market; Galaxy Digital fell 4.24% in pre-market; HCW Biologics rose 196.05% in pre-market; Dreamland rose 106.25% in pre-market; Auddia rose 66.33% in pre-market

Price Alert

Credo Tech

Pre-market hot trades in US stocks: Credo Tech pre-market down 4.63%; Galaxy Digital pre-market down 4.24%